Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Spyre Therapeutics, Inc. Income Statement Banner

Spyre Therapeutics, Inc. Income Statement

SYRE Stock Analysis

Page title

Section title

Breakdown
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
4.628M5.205M3.888M0.0000.00018.739M2.329M886.000K
Cost of Revenue
0.0000.0000.000901.000K1.624M2.001M1.964M964.000K
Gross Profit
4.628M5.205M3.888M-901.000k-1.624m16.738M365.000K-78.000k
Operating Expense
26.402M32.632M49.058M79.433M81.481M84.388M87.110M129.450M
Operating Income
-21.906m-27.676m-45.463m-80.334m-81.481m-65.649m-84.781m-242.303m
Other Income Expense
0.0000.0000.0000.000-5.000k-122.000k-7.000k-19.130m
Total Other Income Expense
208.000K440.000K1.115M2.080M-5.000k-122.000k-7.000k-216.399m
Pretax Income
-21.698m-27.236m-44.348m-78.254m-80.893m-65.660m-83.951m-338.816m
Tax Provision
0.0000.0000.0000.000-593.000k141.000K-136.000k-26.000k
Net Income
-21.698m-27.236m-44.348m-78.254m-80.893m-65.801m-83.815m-338.790m
Basic EPS
-55.400-45.010-53.250-61.230-37.890-25.020-24.860-49.120
Diluted EPS
-55.400-45.010-53.250-61.230-37.890-25.020-24.860-49.120
Basic Average Shares
391.669K605.127K832.902K1.278M2.135M2.630M3.371M6.897M
Diluted Average Shares
391.669K605.127K832.902K1.278M2.135M2.630M3.371M6.897M
Total Expenses
26.534M32.881M49.351M80.334M81.481M84.388M87.110M129.450M
Interest Income
244.000K482.000K1.172M2.143M593.000K111.000K837.000K6.147M
Interest Expense
0.0000.0000.0000.0000.0000.0000.0000.000
EBITDA
-21.774m-27.427m-45.170m-79.433m-80.485m-64.073m-83.214m69.449M
Depreciation & Amortization
132.000K249.000K293.000K901.000K1.624M2.001M1.964M964.000K